Home › Rhabdomyosarcoma › Massachusetts › Boston

Rhabdomyosarcoma clinical trials in Boston, MA

4 studies for Rhabdomyosarcoma are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)

RecruitingPhase 3

Dana-Farber Cancer Institute, Boston

Up to age 50 · All sexes · Updated Aug 25, 2026 · NCT07466316

PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors

RecruitingPhase 1/2

Boston Children's Hospital, Boston
Dana-Farber Cancer Institute, Boston

Ages 1 to 30 · All sexes · Updated Jul 22, 2026 · NCT06721689

VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors

RecruitingPhase 1/2

Boston Children's Hospital, Boston

6 Months – 30 Years · All sexes · Updated Jun 2, 2026 · NCT04796012

Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas

RecruitingPhase 1/2

Boston Children's Hospital, Boston
Dana-Farber Cancer Institute, Boston
Brigham and Women's Hospital, Boston

Ages 12 to 49 · All sexes · Updated Feb 19, 2026 · NCT06709495

Rhabdomyosarcoma trials in other cities

Other studies in Boston

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.